How do you approach DMT choice in a patient with MS with a history of cancer?  

Based on this review (Melamed and Lee, PMID 31998289), patients with MS on several DMTs may be at higher risk for certain cancers. How does this play into your decisions regarding DMT selection?

Answer from: at Academic Institution
at PeaceHealth
In a > 40-year-old patient with 8-month history...
Sign in or Register to read more